Logo

Quorex and IDEC Pharmaceuticals Ink Collaboration

Sep 03, 2003

NEW YORK, Sept. 3 (GenomeWeb News) - Quorex Pharmaceuticals of Carlsbad, Calif., and IDEC Pharmaceuticals of San Diego today announced a research collaboration seeking novel genes encoding proteins for use as therapeutic targets for cancers and inflammatory disorders.

Quorex will apply its Protein Vision bioinformatics tools -- which include genome annotation, homology modeling, and protein-fold prediction tools -- and receive undisclosed up-front and research payments.

Breaking News
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.